CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,546,000 | -21.8% | 357,134 | -8.0% | 0.00% | -100.0% |
| Q3 2021 | $1,977,000 | +5.6% | 388,320 | +31.3% | 0.00% | 0.0% |
| Q2 2021 | $1,872,000 | -17.4% | 295,718 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $2,266,000 | +35.1% | 293,183 | +14.5% | 0.00% | 0.0% |
| Q4 2020 | $1,677,000 | -2.4% | 255,965 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $1,719,000 | +1.3% | 258,535 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $1,697,000 | +5.9% | 203,735 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $1,602,000 | +9.7% | 208,925 | +18.8% | 0.00% | 0.0% |
| Q4 2019 | $1,461,000 | +1.6% | 175,856 | -9.8% | 0.00% | 0.0% |
| Q3 2019 | $1,438,000 | – | 194,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |